Breaking News Instant updates and real-time market news.

VKTX

Viking Therapeutics

$8.60

-0.61 (-6.62%)

07:11
04/18/19
04/18
07:11
04/18/19
07:11

Viking bear thesis based on 'fears and alternative facts,' says H.C. Wainwright

Bear pressure on Viking Therapeutics is "winning by share performance metric," but it is based on "fears and alternative facts," H.C. Wainwright analyst Joseph Pantginis tells investors in a research note. He believes Viking's shares are not reflecting the "compelling data" delivered to date for VK2809, as well as VK5211. The "massive" short interest, currently about 45% of shares outstanding, has been putting "significant pressure on the shares following highly positive news events," says Pantginis. The analyst continues to believe VK2809 represents a potential best-in-class molecule that could "also benefit from the clear definition of regulatory paths and questions established by others." He reiterates a Buy rating on Viking Therapeutics with a $31 price target.

  • 06

    May

  • 09

    May

VKTX Viking Therapeutics
$8.60

-0.61 (-6.62%)

02/22/19
LEER
02/22/19
INITIATION
Target $10
LEER
Market Perform
Viking Therapeutics initiated with a Market Perform at SVB Leerink
SVB Leerink analyst Pasha Sarraf initiated Viking Therapeutics with a Market Perform rating and $10 price target, telling investors in a research note that Viking is positioning VK2809, a hepatic prodrug, thyroid receptor beta-selective agonist for NASH, as it pursues an IND with the GI division, to start Phase 2b trials this year. Sarraf says he is positive on the immunology sector with its diverse indications, continuous innovation, and deep expertise, and is looking long for opportunities in challenging immuno-metabolism and metabolism sectors, in areas like NASH, obesity and diabetes.
03/27/19
HCWC
03/27/19
NO CHANGE
HCWC
Viking data 'impresses again' even at lower dose, says H.C. Wainwright
Viking Therapeutics this morning released the expected data on the 12-week study with the low dose 5 mg arm of VK2809 in patients with non-alcoholic fatty liver disease, H.C. Wainwright analyst Joseph Pantginis tells investors in a research note. As discussed during the recent earnings call, the data released today provide evidence that all patients treated with the lowest dose of VK2809 show significant reduction in liver fat content as measured by magnetic-resonance-imaging, protondensity-fat-fraction, says the analyst. In addition, 100% of patients show greater than or equal to 30% reduction in liver fat content at 12 weeks and 70% of patients demonstrated a reduction in liver fat content of more than 50%, according to Pantginis. He says VK2809 "impresses again even at lower dose" and keeps a Buy rating on Viking Therapeutics with a $31 price target.
03/29/19
LEER
03/29/19
UPGRADE
LEER
Outperform
Viking Therapeutics upgraded to Outperform from Market Perform at SVB Leerink
04/11/19
HCWC
04/11/19
NO CHANGE
Target $31
HCWC
Buy
Viking Therapeutics data 'compelling' at low doses, says H.C. Wainwright
Viking Therapeutics reported additional results this morning from its 12-week Phase 2 data of the lower 5mg dose of VK2809 in patients with non-alcoholic fatty liver disease. The "compelling" results show "impressive" safety and efficacy at low doses, H.C. Wainwright analyst Joseph Pantginis tells investors in a research note. Importantly, VK2809 at low doses is able to "significantly reduce" liver fat content in 12 weeks to an extent similar to the one demonstrated by the higher doses tested, says the analyst. He reiterates a Buy rating on Viking Therapeutics with a $31 price target.

TODAY'S FREE FLY STORIES

GPS

Gap

$16.66

-0.36 (-2.12%)

10:55
12/13/19
12/13
10:55
12/13/19
10:55
Options
Gap put volume heavy and directionally bearish »

Bearish flow noted in Gap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:55
12/13/19
12/13
10:55
12/13/19
10:55
Conference/Events
Federal Reserve Bank of New York president participates in a discussion »

New York Federal Reserve…

SPT

Sprout Social

$0.00

(0.00%)

10:52
12/13/19
12/13
10:52
12/13/19
10:52
Syndicate
Sprout Social indicated to open at $19.25, IPO priced at $17.00 »

Sprout Social (SPT)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$317.49

0.35 (0.11%)

10:47
12/13/19
12/13
10:47
12/13/19
10:47
General news
U.S. Trade Representative says Phase One trade deal with China 'enforceable' »

United States Trade…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$317.49

0.35 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$286.83

3.03 (1.07%)

10:45
12/13/19
12/13
10:45
12/13/19
10:45
Options
UnitedHealth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/13/19
12/13
10:45
12/13/19
10:45
General news
Breaking General news story  »

New York Federal Reserve…

10:45
12/13/19
12/13
10:45
12/13/19
10:45
General news
Breaking General news story  »

New York Federal Reserve…

ALG

Alamo Group

$117.70

0.51 (0.44%)

10:43
12/13/19
12/13
10:43
12/13/19
10:43
Conference/Events
Alamo Group management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

ABT

Abbott

$86.48

0.5 (0.58%)

10:40
12/13/19
12/13
10:40
12/13/19
10:40
Hot Stocks
Abbott raises quarterly dividend 12.5% to 36c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPO

Exponent

$65.46

-0.62 (-0.94%)

10:37
12/13/19
12/13
10:37
12/13/19
10:37
Conference/Events
Exponent management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FLWS

1-800-Flowers.com

$13.56

0.29 (2.19%)

10:35
12/13/19
12/13
10:35
12/13/19
10:35
Conference/Events
1-800-Flowers.com management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

FFIV

F5 Networks

$142.79

-0.84 (-0.58%)

10:35
12/13/19
12/13
10:35
12/13/19
10:35
Periodicals
Police raid Moscow office of F5 Networks' NGINX, ZDNet reports »

On Thursday, police…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$8.89

0.21 (2.42%)

10:35
12/13/19
12/13
10:35
12/13/19
10:35
Options
Spectrum put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$133.61

33.22 (33.09%)

10:34
12/13/19
12/13
10:34
12/13/19
10:34
On The Fly
Sarepta jumps as analysts react to 'surprise' FDA reversal on Vyondys53 »

Shares of Sarepta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$17.02

(0.00%)

10:32
12/13/19
12/13
10:32
12/13/19
10:32
Hot Stocks
Gap's Old Navy unit teams up with Postmates for on-demand gift delivery »

Gap's Old Navy unit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
12/13/19
12/13
10:30
12/13/19
10:30
General news
Treasury Action: yields remain lower, led by the front end, amid a lack of clarity »

Treasury Action: yields…

10:30
12/13/19
12/13
10:30
12/13/19
10:30
General news
The October U.S. business inventory report tracked estimates »

The October U.S. business…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$317.78

0.64 (0.20%)

10:29
12/13/19
12/13
10:29
12/13/19
10:29
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Trump says Phase Two…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$317.78

0.64 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$318.00

0.86 (0.27%)

10:29
12/13/19
12/13
10:29
12/13/19
10:29
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Trump says 25% tariffs on…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$318.00

0.86 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$318.23

1.09 (0.34%)

10:27
12/13/19
12/13
10:27
12/13/19
10:27
General news
Trump says Dec. 15 tariffs will not be charged due to phase one deal »

President Trump just…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$318.23

1.09 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$23.91

0.91 (3.96%)

10:25
12/13/19
12/13
10:25
12/13/19
10:25
Options
Amarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

MSFT

Microsoft

$154.18

0.95 (0.62%)

10:25
12/13/19
12/13
10:25
12/13/19
10:25
Hot Stocks
Microsoft unveils Xbox Series X, available Holiday 2020 »

Microsoft announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
12/13/19
12/13
10:25
12/13/19
10:25
General news
FX Action: USD-JPY »

FX Action: USD-JPY is…

10:25
12/13/19
12/13
10:25
12/13/19
10:25
Conference/Events
JPMorgan media analyst to hold an analyst/industry conference call »

Media Analyst Quadrani…

QSR

Restaurant Brands

$66.41

-0.105 (-0.16%)

, PZZA

Papa John's

$60.62

0.15 (0.25%)

10:19
12/13/19
12/13
10:19
12/13/19
10:19
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

QSR

Restaurant Brands

$66.41

-0.105 (-0.16%)

PZZA

Papa John's

$60.62

0.15 (0.25%)

COP

ConocoPhillips

$63.35

0.77 (1.23%)

VIAC

ViacomCBS

$38.42

0.63 (1.67%)

SAFM

Sanderson Farms

$167.90

1.24 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

  • 04

    Feb

  • 23

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.